Annual Report
    
News

    
Directory / Bottin
Contact Us
Directions / Maps
Steering Committee
Events & Seminars
MDRC at the forefront
McGarry Lecture
Cahill Lecture
MDRC Core Facilities
Scientific Links
Education & Employment

    
MDRC Grants
Donations
Non-Profit & Industrial Partners
    
JDRF
CDA
Diabetes Quebec
ADA
IDF
NIH / NIDDK
Alfediam
EASD
Français
 Home / About Us> Research > MDRC at the forefront

MDRC at the forefront

 

 


Over $2.5 million to Rémi Rabasa-Lhoret for research on the artificial pancreas. Dr Rémi Rabasa-Lhoret research team at IRCM is receiving a grant of more than $2.5M USD from the U.S. NIH for a clinical study on external artificial pancreas. The goal of the project is to compare glucose control achieved using the single-hormone (insulin only) artificial pancreas, the dual-hormone (insulin and glucagon) artificial pancreas, and the conventional insulin pump to deliver insulin.

Dr Rabasa-Lhoret team is leading the field of artificial pancreas development in Canada, a technology which has the potential to greatly reduce complication risks associated to a poor glucose control in people with type 1 diabetes. Click here for the IRCM news release.

 

 

Dr Vincent Poitout was elected Fellow of the Canadian Academy of Health Sciences.

 

 

AmorChem venture capital fund invests at MDRC. Two projects of the MDRC researchers Marc Prentki and Nabil Seidah have recently been funded by the venture capital fund AmorChem: more than 1 million and 1.5 million $, respectively. The shareholders of this fund are the Quebec government, Fonds de solidarité FTQ and Merck. The mission of AmorChem is to increase the commercial value of academic research discoveries in Quebec. Click here for an article in La Presse about this news (in French).

 

 

MDRC success for a CFI competition - Creation of the BIOcMET consortium. The Canada Foundation for Innovation (CFI) announced last January 15 the attribution of a 6.5 million $ grant to fund the project entitled "The Montreal Cardiometabolic biomarker and drug discovery consortium (BIOcMET)". This project is led by Dr Marc Prentki, MDRC director. Among the 10 investigators involved in the project, 8 are MDRC members: Drs Prentki, Poitout, Hamet, Turgeon, Gaudreau (UdM/CRCHUM), Rabasa-Lhoret, Seidah (UdM/IRCM) and Sladek (McGill). The two other researchers are Drs Blanchette (McGill) and Coulombe (UdM/IRCM).

 

 

Marc Prentki received the 2011 Albert Renold Prize from the European Association for the Study of Diabetes (EASD) for "outstanding achievements in research on the islets of Langerhans".

As part of the prize, Dr Prentki was invited to give the Albert Renold Lecture at the 2011 EASD annual meeting. The title of his talk was: "Tricycling along the β-cell and its coupling mechanisms for fuel-induced insulin secretion".

 

 

2011 is an exceptional year of Canadian Diabetes Association (CDA) funding for MDRC members: 8 of the 24 projects funded across Canada this year were granted to MDRC members!

 

 

Pedro Geraldes receives the prestigious "Scholar Award" of the CDA attributed to newly independent investigators establishing diabetes-related research in a Canadian university.

 

 

Marc Prentki and Vincent Poitout's works have been highlighted in Le donataire. A full page of the June edition of Le donataire, the monthly newsletter of the CHUM foundation, has been dedicated to describing the achievements of the laboratories of Drs Marc Prentki and Vincent Poitout. Click here for a pdf version of the publication.

 

 

The Bioartificial Pancreas and other
         Biohybrid Therapies

Jean-Pierre Hallé and Lawrence Rosenberg have edited a book on bioartificial therapies and tissue transplantations. Eighty-one scientists from 32 institutions in 12 different countries have contributed to the book entitled “The Bioartificial Pancreas and other Biohybrid Therapies”, edited by Drs Hallé and Rosenberg.

 

 

 



© Montreal Diabetes Research Center 2017
Home / About Us   News   Directory / Bottin   Contact Us